As of August 28, 2026, The Oncology Institute, Inc. (TOI) has a DilutionWatch DilutionScore of 65/100, rated HIGH dilution risk. The Oncology Institute, Inc. has a market capitalization of $468.92M, 101.92M shares outstanding. Stored dilution-related fields include 5.75M outstanding warrants.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
model est. 35%
💰 Capital Raise
model 55%
• Critical: only 0.1 months cash remaining
🔄 Reverse Split
model est. 15%
• Only 0 months cash — financial pressure
📜 Warrant Exercise
model 15%
• Warrant overhang: 5.6% of shares outstanding
Market Data
Market Cap$468.92M
Shares Outstanding101.92M
Float87.41M
Cash$200.0K
Debt$80.05M
Short InterestN/A
Institutional Holdings
46.0% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
Short Interest
Short Interest7.15M
Days to Cover4.8
% of Float8.2%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL WARRANT
2025-12-31
xbrl
XBRL CONVERTIBLE
2025-03-24
4
INSIDER TRANSACTION
2026-04-01
4
INSIDER TRANSACTION
2026-04-01
4
INSIDER TRANSACTION
2026-04-01
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual TOI Dilution Snapshot
The Oncology Institute, Inc. (TOI) has a DilutionScore of 65/100, rated High dilution risk. Score date: August 28, 2026.
- Stored outstanding warrants: 5.8M.
- Recent SEC activity tracked for TOI: 4 on 2026-04-01; 4 on 2026-04-01; 4 on 2026-04-01.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track TOI Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking TOI — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for TOI
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.